Przejdź do zawartości
Merck
  • In vitro inhibition of thrombin generation, after tissue factor pathway activation, by the oral, direct factor Xa inhibitor rivaroxaban.

In vitro inhibition of thrombin generation, after tissue factor pathway activation, by the oral, direct factor Xa inhibitor rivaroxaban.

Journal of thrombosis and haemostasis : JTH (2007-03-29)
G T Gerotziafas, I Elalamy, F Depasse, E Perzborn, M M Samama
MATERIAŁY
Numer produktu
Marka
Opis produktu

Sigma-Aldrich
Rivaroxaban, ≥98% (HPLC)